Single-Use Negative Pressure Wound Therapy Devices Market Research Report and Outlook by 2028

The market for single-use negative pressure wound therapy (NPWT) devices is anticipated to grow significantly, reaching an estimated US$ 892.3 million by 2028, up from US$ 498.3 million in 2021. This growth represents a compound annual growth rate (CAGR) of 8.8% from 2021 to 2028.

The rise in the incidence of wounds due to various factors such as burns, surgical procedures, trauma, and other medical conditions is expected to drive the demand for effective wound management solutions, thereby propelling market growth.

Chronic diseases, which are defined as health conditions lasting a year or more and requiring ongoing medical attention, significantly impact daily life and are prevalent in the United States. Major chronic illnesses, including heart disease, cancer, and diabetes, are leading causes of death and disability. The substantial number of patients in North America suffering from chronic conditions, particularly diabetes, has contributed to the rapid expansion of the NPWT market. Diabetic foot ulcers are a common complication among individuals with diabetes, further increasing the need for NPWT solutions. The rising prevalence of chronic conditions, such as obesity and both type I and type II diabetes, has heightened the demand for negative pressure wound therapy devices, thus benefiting market growth. Additionally, growing patient awareness regarding affordable NPWT options, including single-use devices, along with an increase in trauma-related fatalities, has supported market expansion.

In 2019, there were approximately 8,378,122 new burn cases reported globally, with a significant portion of these cases occurring in low- and middle-income countries, where child burn mortality rates are about seven times higher than in high-income nations. The single-use NPWT system is designed to manage both acute and chronic wounds, as well as closed surgical incisions with low to moderate levels of exudate. This therapy involves applying negative pressure to a wound, which aids in healing by promoting drainage of excess fluid and enhancing localized blood circulation. Other terms for NPWT include topical negative pressure therapy, vacuum-assisted closure, and sealed surface wound suction. The application of NPWT is particularly beneficial for burn patients, as it is believed to enhance oxygen and nutrient delivery to the wound, thereby facilitating healing. The single-use NPWT system is suitable for various wound types, including chronic, acute, traumatic, subacute, dehisced wounds, partial-thickness burns, ulcers (such as diabetic or pressure ulcers), flaps and grafts, and closed surgical incisions.

According to the Children's Burn Trust and the British Burn Association, around 625 children are admitted monthly to NHS Burns Services due to burn or scald injuries. In 2017, the NHS treated over 15,000 patients for burns and scalds, incurring costs exceeding US$ 24.94 million (approximately GBP 20 million). Among these, more than 40 cases were classified as extremely serious, with treatment costs averaging over US$ 118,455.50 (GBP 95,000) per patient. The incidence of burns resulting from domestic and industrial accidents is on the rise in developing regions, including Asia Pacific, Africa, and the Middle East, further driving the demand for single-use negative pressure wound care devices.

The COVID-19 pandemic has placed immense pressure on healthcare systems worldwide. To mitigate the risk of virus transmission, many healthcare providers postponed elective and preventive care, opting for telemedicine where feasible. The impact of the pandemic on the single-use NPWT devices market has been mixed. Despite the challenges, wound management remains a critical area of healthcare, with a consistent demand for single-use NPWT devices, which help minimize contamination risks. Developed regions have experienced steady demand for these devices, while developing countries in Asia Pacific and the Middle East & Africa faced challenges due to supply chain disruptions. However, with the successful rollout of vaccines, the demand for NPWT devices is beginning to recover as healthcare services and wound clinics resume normal operations.

The global market for single-use negative pressure wound therapy devices is categorized by wound type and end user. The wound type segmentation includes surgical wounds, ulcers, traumatic burns, flaps and grafts, sports injuries, and burns. The traumatic segment held the largest market share in 2021 and is projected to exhibit the highest CAGR during the forecast period, driven by the increasing incidence of accidents and trauma cases worldwide.

In terms of end users, the market is divided into hospitals, clinics, ambulatory surgical centers, and others. The hospital segment dominated the market in 2021 and is expected to maintain the highest growth rate during the forecast period.

Key organizations and associations, such as the Australian Medical Association, European Wound Management Association, Nurses Specializing in Wound, Ostomy and Continence Canada, Japan Society for Surgical Wound Care, and the Association for Burns Injuries Singapore, have been referenced in the preparation of this report on the single-use negative pressure wound therapy devices market.